Sort
64,565 grants matching “drug discovery”
Transformational next generation high affinity trispecific fab protein to address unmet needs in Ophthalmology
$933,533Li Xu · Revopsis Therapeutics, Inc. · R44 · FY2024 · EY
Transformational next generation high affinity trispecific fab protein to address unmet needs in Ophthalmology
$933,533Li Xu · Revopsis Therapeutics, Inc. · R44 · FY2025 · EY
Glycosaminoglycan-Interacting Small Molecule (GISMO) as Alzheimer's Therapeutics
$933,415Paul Gregor · Gismo Therapeutics, Inc. · R44 · FY2017 · AG
Split-Maze Discovery of Antiobesity Drugs
$933,335Novasite Pharmaceuticals, Inc. · R44 · FY2003 · DK
RNA: Structure, Biophysics and Physiology
$933,275Adrian Ferre-D'amare · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL
Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart Failure
$933,000Kory J. Lavine · Washington University · R35 · FY2025 · HL
The Development of a Web-based Data Retrieval System for HIV Therapy Guidance
$932,999Christos J Petropoulos · Monogram Biosciences, Inc. · R44 · FY2008 · AI
New Ways of Targeting K-Ras
$932,874Frank Patrick McCormick · University Of California, San Francisco · R35 · FY2016 · CA
Novel Antibiotics from Unculturable Actinomycetes
$932,873Novobiotic Pharmaceuticals, Llc · R01 · FY2005 · AI
Plasmonic Scattering Microscopy for high-throughput in-situ quantification of molecular binding kinetics on single cells
$932,810Nguyen Ly · Biosensing Instrument, Inc. · R42 · FY2025 · GM
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation
$932,722Haian Fu · Emory University · U01 · FY2020 · CA
Development of an inhibitory oligonucleotide for the treatment of lupus
$932,510Robert L Coffman · Dynavax Technologies Corporation · R44 · FY2009 · AI
Systematic discovery of neomorph protein-protein interactions in cancer for oncogenic pathway perturbation
$932,391Haian Fu · Emory University · U01 · FY2021 · CA
DNA Topoisomerases as Target of Action of Anticancer Drugs
$932,263Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
$931,980Sanford D Markowitz · Case Western Reserve University · R35 · FY2022 · CA
Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment
$931,980Sanford D Markowitz · Case Western Reserve University · R35 · FY2023 · CA
HIV RNase H natural product inhibitors
$931,781Michael A Parniak · University Of Pittsburgh At Pittsburgh · U19 · FY2007 · AI
Discovery, Structural Studies and Biosynthesis of Biologically Active Natural Products and Natural Product-Like Inhibitors
$931,691Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Discovery of Natural Products and Natural Product-Like Inhibitors
$931,691Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Discovery of Natural Products and Natural Product-Like Inhibitors
$931,690Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Synthesis of non-GMP Small Molecules
$931,000Dumitru Ionescu · Ash Stevens, Inc. · N02 · FY2010 · CA
Core B Medicinal Chemistry
$930,949Joel Stephen Freundlich · Hackensack University Medical Center · U19 · FY2022 · AI
Core C Pharmacology
$930,948Vidmantas Petraitis · Hackensack University Medical Center · U19 · FY2023 · AI
Genomic Medicine Implementation: The Personalized Medicine Program
$930,567Julie A. Johnson · University Of Florida · U01 · FY2017 · HG
Defining and Manipulating Epigenomic Regulators in Endogenous Systems
$930,474Jordan Leslie Meier · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA